Showing 1031-1040 of 20385 results for "".
Beyond IOP: Integrating Ocular Surface Resilience Into Glaucoma Management
https://reachmd.com/programs/cme/beyond-iop-integrating-ocular-surface-resilience-into-glaucoma-management/49097/Our experts discuss management strategies for individualized ocular surface rehabilitation while maintaining optimal IOP control in patients with glaucoma.Diagnosing IBD: Is It IBD or Something Else? Can You Tell?
https://reachmd.com/programs/cme/diagnosing-ibd-is-it-ibd-or-something-else-can-you-tell/51480/Explore IBD from diagnosis to remission with practical cases, treatment strategies, and a treat-to-target approach for optimal patient outcomes.Clear Skin, Clear Path: Transforming Psoriasis Care with Durable Biologic and Oral IL-23 Innovations
https://reachmd.com/programs/cme/clear-skin-clear-path-transforming-psoriasis-care-with-durable-biologic-and-oral-il-23-innovations/49227/Join us to learn practical strategies for earlier systemic therapy initiation and why you should consider integrating oral IL-23 inhibitors into psoriasis management.Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
https://reachmd.com/programs/cme/beyond-igf-1r-il-6r-inhibition-and-future-sequencing/60946/Explore how experts are rethinking TED severity and integrating modern therapies to personalize treatment and manage individual disease burden.RAS(ON) and Beyond: Clinical Integration and Strategic Sequencing
https://reachmd.com/programs/cme/rason-and-beyond-clinical-integration-and-strategic-sequencing/54124/Explore ON-state RAS inhibitors for the treatment of NSCLC and pancreatic cancer, including mechanisms, efficacy data, and integration into clinical practice.Long-term improvements in daily steps with gamification and financial incentives in patients at risk for CV events
https://reachmd.com/programs/acc-action-center/long-term-improvements-in-daily-steps-with-gamification-and-financial-incentives-in-patients-at-risk-for-cv-events/24347/ACC.24 - Alexander Fanaroff shares the results of the BE ACTIVE trial, which investigated the long-term efficacy of gamification, financial incentives, or a combination of both approaches for increasing physical activity in patients at risk for cardiovascular events.Virtual IBD Clinic: Diagnosis and Medical Treatment
https://reachmd.com/programs/cme/virtual-ibd-clinic-diagnosis-and-medical-treatment/11442/Explore the diagnosis and treatment of a young patient who presents with symptoms that are consistent with inflammatory bowel diseases (IBD).IBD Masterclass: Choosing the Right IBD Therapy - A Patient-Clinician Connection
https://reachmd.com/programs/cme/ibd-masterclass-choosing-the-right-ibd-therapy-a-patient-clinician-connection/54374/A case-based discussion of therapy selection, de-escalation, and treat-to-target approaches in inflammatory bowel disease management.Understanding the Mechanism Behind a Treatment Approach in Indolent Systemic Mastocytosis (ISM)
https://reachmd.com/programs/medical-industry-feature/mechanism-treatment-approach-indolent-systemic-mastocytosis-ism/32766/Historically, indolent systemic mastocytosis (ISM) care focused on treating symptoms. AYVAKIT® (avapritinib) targets the KIT D816V mutation, the underlying cause of ISM.3,4 Learn how AYVAKIT can play a role in treating patients with ISM.1Talking Through Treatment: Patient–Clinician Dialogue on Perioperative Immunotherapy in Locally Advanced HNSCC
https://reachmd.com/programs/cme/talking-through-treatment-patientclinician-dialogue-on-perioperative-immunotherapy-in-locally-advanced-hnscc/56431/Explore perioperative immunotherapy in locally advanced HNSCC through patient–clinician dialogue, clinical evidence, and multidisciplinary care.